Abstract
The renin-angiotensin system (RAS) is involved in physiological and pathological processes. Currently, a new paradigm has emerged. It has that two main axes that modulate the SRA function: an axis ACE / Ang II / AT1 receptor, and another ACE2 / Ang- (1-7) / MAS receptor. These functional aspects increase the range of possible targets for the treatment of cardiovascular diseases, including…